← Leaderboards
Samuel S Yen
University Of California San Diego
$0
Attributed
$0
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$0 · 2
By mechanism
M01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California San Diego
Same institution · by research overlap
- R Jeffrey Chang$12,222,781
- Jerrold M Olefsky$29,583,289
- Pamela L Mellon$36,611,301
- Jeffrey T Chang$4,144,512
- Shunichi Shimasaki$7,451,712
Others in their field
Top investigators on “Women'S Health”
- Chanza Baytop · Westat, Inc.$271,217,917
- Wafaa M. El-Sadr · Columbia University Health Sciences$240,499,512
- Sharon A Nachman · Johns Hopkins University$213,337,729
- Myron S Cohen · Family Health International$206,489,087
- Barbara Driver · Westat, Inc.$200,651,985
- Carol Nesel · Westat$188,148,170
Research focus
Women'S HealthClinical ResearchFemaleHuman SubjectHuman Therapy EvaluationDrug Screening /EvaluationEstrogensTransdermal Drug DeliveryHormone TherapyTroglitazoneAdrenal DisorderImmunoregulationMenstrual Cycle DisorderOral AdministrationOvulationPolycystic Ovary SyndromeAgingReproductive System Disorder ChemotherapyDehydroepiandrosteroneDrug Adverse Effect
Grant awards (18)
TROGLITAZONE IN TREATMENT OF POLYCYSTIC OVARY SYNDROME$0
M01 · FY2002 · RR
HORMONE REPLACEMENT AFFECTS ROLE OF DHEA IN WOMEN OF ADVANCED AGE$0
M01 · FY2002 · RR
HORMONE REPLACEMENT AFFECTS ROLE OF DHEA IN WOMEN OF ADVANCED AGE$0
M01 · FY2002 · RR
HORMONE REPLACEMENT AFFECTS ROLE OF DHEA IN WOMEN OF ADVANCED AGE$0
M01 · FY2002 · RR
TROGLITAZONE IN TREATMENT OF POLYCYSTIC OVARY SYNDROME$0
M01 · FY2002 · RR
HORMONE REPLACEMENT AFFECTS ROLE OF DHEA IN WOMEN OF ADVANCED AGE$0
M01 · FY2002 · RR
TROGLITAZONE IN TREATMENT OF POLYCYSTIC OVARY SYNDROME$0
M01 · FY2002 · RR
TROGLITAZONE IN TREATMENT OF POLYCYSTIC OVARY SYNDROME$0
M01 · FY2002 · RR
TROGLITAZONE IN TREATMENT OF POLYCYSTIC OVARY SYNDROME$0
M01 · FY2001 · RR
HORMONE REPLACEMENT AFFECTS ROLE OF DHEA IN WOMEN OF ADVANCED AGE$0
M01 · FY2001 · RR
HORMONE REPLACEMENT AFFECTS ROLE OF DHEA IN WOMEN OF ADVANCED AGE$0
M01 · FY2001 · RR
TROGLITAZONE IN TREATMENT OF POLYCYSTIC OVARY SYNDROME$0
M01 · FY2001 · RR
HORMONE REPLACEMENT AFFECTS ROLE OF DHEA IN WOMEN OF ADVANCED AGE$0
M01 · FY2000 · RR
TROGLITAZONE IN TREATMENT OF POLYCYSTIC OVARY SYNDROME$0
M01 · FY2000 · RR
TROGLITAZONE IN TREATMENT OF POLYCYSTIC OVARY SYNDROME$0
M01 · FY2000 · RR
TROGLITAZONE IN TREATMENT OF POLYCYSTIC OVARY SYNDROME$0
M01 · FY2000 · RR
HORMONE REPLACEMENT AFFECTS ROLE OF DHEA IN WOMEN OF ADVANCED AGE$0
M01 · FY2000 · RR
HORMONE REPLACEMENT AFFECTS ROLE OF DHEA IN WOMEN OF ADVANCED AGE$0
M01 · FY2000 · RR